'Open Access - Open Data' Conference to take place December 13 - 14, 2010 in Cologne

From December 13 - 14, 2010, the "Open Access - Open Data" Conference will be taking place in Cologne. It is an international expert conference that will look closely on how the Open Access movement has developed within the last five years and what is going to happen within the next five to ten years. Additionally, the "Open Data Movement" that is gaining more and more importance will be under consideration.

The conference is organized by Goportis, the Leibniz Library Network for Research Information. Open Access is one of the fields of competence of Goportis.

Goportis is the name of the Leibniz Library Network for Research Information.

Partners in Goportis are the three German National Libraries TIB (German National Library of Science and Technology, Hanover), ZB MED (German National Library of Medicine, Cologne/Bonn) and ZBW (German National Library of Economics - Leibniz Information Centre for Economics, Kiel/Hamburg). Goportis is the expert partner in Germany for the following competence fields: Full text service, licences, non-textual materials, long-term preservation and Open Access.

http://www.oaod2010.de

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New AI tool maps millions of CD8+ T cells to advance disease research